STOCK TITAN
  1. Home
  2. Sec-filings
  3. AORT
  4. [Form 4] ARTIVION, INC. Insider Trading Activity

Artivion (AORT) director receives 7,576-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Burbank Jeffrey H reported acquisition or exercise transactions in this Form 4 filing.

ARTIVION, INC. director Jeffrey H. Burbank received a grant of 7,576 shares of Common Stock on May 18, 2026, at no purchase price. The RSA grant is scheduled to vest on May 18, 2027, under the company’s Equity and Cash Incentive Plan. Following this award, he directly holds 61,372 shares of Artivion stock.

Positive

  • None.

Negative

  • None.

Insights

Director receives time-vested equity grant as routine compensation.

Director Jeffrey H. Burbank was granted 7,576 shares of ARTIVION, INC. Common Stock at no purchase price, characterized as a grant or award under the company’s Equity and Cash Incentive Plan. This is compensation-related, not an open-market purchase.

The RSA grant vests on May 18, 2027, meaning the shares are subject to continued-service or similar conditions until that date. After the award, Burbank holds 61,372 shares directly, indicating this filing reflects ongoing equity-based compensation rather than a change in trading sentiment.

Insider Burbank Jeffrey H
Role null
Type Security Shares Price Value
Grant/Award Common Stock 7,576 $0.00 --
Holdings After Transaction: Common Stock — 61,372 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares granted 7,576 shares Common Stock grant on May 18, 2026
Grant price $0.0000 per share Equity award, non-cash compensation
Shares owned after grant 61,372 shares Total direct holdings following transaction
Vesting date May 18, 2027 RSA grant vests under Equity and Cash Incentive Plan
RSA Grant financial
"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."
Equity and Cash Incentive Plan financial
"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
transaction code "A" regulatory
"transaction_code_description": "Grant, award, or other acquisition""
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burbank Jeffrey H
(Last)(First)(Middle)
ARTIVION INC
1655 ROBERTS BLVD NW
(Street)
KENNESAW GEORGIA 30144
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/18/2026A7,576(1)A$061,372D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
Remarks:
/s/ Jeffrey H. Burbank05/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Artivion (AORT) director Jeffrey Burbank report in this Form 4?

Director Jeffrey H. Burbank reported receiving a grant of 7,576 Artivion Common Stock shares. The shares were awarded at no purchase price as equity compensation and increase his direct holdings to 61,372 shares after the transaction.

Was the Artivion (AORT) Form 4 transaction a market purchase or sale?

The Form 4 shows a grant or award acquisition, not a market trade. Burbank received 7,576 shares at a price of $0.0000 per share as equity compensation, so it does not represent an open-market buy or sell decision.

When does Jeffrey Burbank’s 7,576-share Artivion (AORT) RSA grant vest?

The RSA grant of 7,576 Artivion shares to director Jeffrey Burbank is scheduled to vest on May 18, 2027. Vesting is pursuant to the company’s Equity and Cash Incentive Plan, meaning the shares become fully earned on that date.

How many Artivion (AORT) shares does Jeffrey Burbank own after this grant?

Following the equity award, Jeffrey Burbank directly owns 61,372 shares of Artivion Common Stock. This total includes the 7,576-share grant reported in the Form 4, which was received as a non-cash stock award under the company plan.

What does transaction code "A" mean in the Artivion (AORT) Form 4?

Transaction code "A" on this Form 4 denotes a grant, award, or other acquisition of securities. In this filing, it reflects a 7,576-share stock award to director Jeffrey Burbank, received at no purchase cost under Artivion’s Equity and Cash Incentive Plan.